AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33593767 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV and tetanus/diphtheria booster vaccine
Number of subjects: 0
Study 33593767 — intervention group
Group type: EXPERIMENTAL
Intervention: Schistosomiasis intervention (trial A)
Number of subjects: 0
Study 33593767 — intervention group
Group type: EXPERIMENTAL
Intervention: Malaria intervention (trial B)
Number of subjects: 0
Study 33593767 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG revaccination (trial C)
Number of subjects: 0
Study 33218522 — intervention group
Group type: EXPERIMENTAL
Intervention: Bowen Therapy (real therapy)
Number of subjects: 31
Study 33218522 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (control)
Number of subjects: 31
Study 36384219 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision making (SDM) intervention
Number of subjects: 310
Study 32986891 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (60 mg/d)
Number of subjects: 14
Study 32986891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 32325428 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice bag
Number of subjects: 11
Study 32325428 — intervention group
Group type: EXPERIMENTAL
Intervention: Saltwater pack
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Chilled surgical steel enswell
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Copper
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Commercial cold pack
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Aluminum
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Brass
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Ice cube
Number of subjects: 11
Study 32325428 — intervention group
Group type: COMPARATOR
Intervention: Ice pack
Number of subjects: 11
Study 33482793 — intervention group
Group type: EXPERIMENTAL
Intervention: Training ward staff in accordance with falls prevention guidelines
Number of subjects: 0
Study 33482793 — intervention group
Group type: COMPARATOR
Intervention: Control phase (no intervention)
Number of subjects: 0
Study 35993151 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-oriented informative and motivational leaflet
Number of subjects: 140
Study 35993151 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who stepped down or off PPI
Number of subjects: 140
Study 35993151 — intervention group
Group type: COMPARATOR
Intervention: Control group (no leaflet)
Number of subjects: 140
Study 33906073 — intervention group
Group type: EXPERIMENTAL
Intervention: Policaptil Gel Retard (PGR), 6 tablets/day
Number of subjects: 100
Study 33906073 — intervention group
Group type: COMPARATOR
Intervention: Metformin, 1500–2000 mg/day in two divided doses
Number of subjects: 100
Study 33906073 — intervention group
Group type: EXPERIMENTAL
Intervention: Policaptil Gel Retard (PGR)
Number of subjects: 100
Study 33687559 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum effort swallowing
Number of subjects: 43
Study 33687559 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum effort swallowing
Number of subjects: 43
Study 33687559 — intervention group
Group type: COMPARATOR
Intervention: Regular effort swallowing
Number of subjects: 43
Study 32840955 — intervention group
Group type: EXPERIMENTAL
Intervention: Professionally-based cognitive-behavioral therapy for insomnia (PCBT-I)
Number of subjects: 161
Study 32840955 — intervention group
Group type: COMPARATOR
Intervention: Video-based cognitive-behavioral therapy for insomnia (VCBT-I)
Number of subjects: 161
Study 33504955 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline (200 mg/day)
Number of subjects: 39
Study 33504955 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 33504955 — intervention group
Group type: EXPERIMENTAL
Intervention: Minocycline
Number of subjects: 39
Study 32466881 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB) Angioplasty
Number of subjects: 1958
Study 32466881 — intervention group
Group type: COMPARATOR
Intervention: Repeat Drug-Eluting Stent (DES) Implantation
Number of subjects: 1958
Study 36069596 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron repletion (1 g low‐molecular‐weight iron dextran)
Number of subjects: 79
Study 33792453 — intervention group
Group type: EXPERIMENTAL
Intervention: Zilucoplan
Number of subjects: 0
Study 33792453 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32967685 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol maleate 150 μg once daily (o.d.)
Number of subjects: 54
Study 32967685 — intervention group
Group type: EXPERIMENTAL
Intervention: Indacaterol acetate 150 μg once daily (o.d.)
Number of subjects: 54
Study 32967685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 35108222 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 brushing times
Number of subjects: 443
Study 35108222 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 brushing times
Number of subjects: 443
Study 35108222 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 brushing times
Number of subjects: 443
Study 34994614 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 94
Study 34994614 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 94
Study 35359168 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 12 mg
Number of subjects: 1000
Study 35359168 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone 6 mg
Number of subjects: 1000
Study 33259449 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 58
Study 33259449 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (Control)
Number of subjects: 58
Study 35190407 — intervention group
Group type: EXPERIMENTAL
Intervention: ivWatch monitoring in addition to standard care
Number of subjects: 200
Study 35190407 — intervention group
Group type: COMPARATOR
Intervention: Standard care (clinical observation)
Number of subjects: 200
Study 34543725 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based peer-led sexual and reproductive health services with a loyalty card system
Number of subjects: 0
Study 34543725 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32478922 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic supplementation (1,000 mg for 8 weeks)
Number of subjects: 70
Study 32478922 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 33177439 — intervention group
Group type: EXPERIMENTAL
Intervention: Wall-mounted suction
Number of subjects: 73
Study 33177439 — intervention group
Group type: COMPARATOR
Intervention: Handheld syringe suction
Number of subjects: 73
Study 35903377 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosaprepitant-containing regimen (fosaprepitant, granisetron, and dexamethasone)
Number of subjects: 341
Study 35903377 — intervention group
Group type: COMPARATOR
Intervention: Aprepitant-containing regimen (aprepitant, granisetron, and dexamethasone)
Number of subjects: 341
Study 35903377 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosaprepitant
Number of subjects: 341
Study 32763217 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg film-coated tablets
Number of subjects: 62
Study 32763217 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 mg film-coated tablets
Number of subjects: 62
Study 32763217 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg film-coated tablets or 30 mg dispersible tablets
Number of subjects: 62
Study 32763217 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg dispersible tablets or 50 mg film-coated tablets
Number of subjects: 62
Study 35551331 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 32006033 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal eye masks
Number of subjects: 70
Study 32006033 — intervention group
Group type: COMPARATOR
Intervention: No eye masks (control)
Number of subjects: 70
Study 35796669 — intervention group
Group type: COMPARATOR
Intervention: GIP in non-CF controls
Number of subjects: 32
Study 34414653 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Positive Deviance/Hearth (PDH) programme with in-person visits
Number of subjects: 361
Study 34414653 — intervention group
Group type: EXPERIMENTAL
Intervention: PDH with Interactive Voice Calling (PDH-IVC)
Number of subjects: 361
Study 34414653 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 361
Study 35963559 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐methylphenidate
Number of subjects: 181
Study 35963559 — intervention group
Group type: EXPERIMENTAL
Intervention: guanfacine
Number of subjects: 181
Study 35963559 — intervention group
Group type: EXPERIMENTAL
Intervention: combined treatment
Number of subjects: 181
Study 35963559 — intervention group
Group type: EXPERIMENTAL
Intervention: combined treatment and guanfacine
Number of subjects: 181
Study 35963559 — intervention group
Group type: COMPARATOR
Intervention: clinical measures alone
Number of subjects: 181
Study 33452967 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcuma longa (1000 mg/day)
Number of subjects: 24
Study 33452967 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconia albicans (1000 mg/day)
Number of subjects: 24
Study 33452967 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen (1200 mg/day)
Number of subjects: 24
Study 32798677 — intervention group
Group type: EXPERIMENTAL
Intervention: 3T exFAT trajectories
Number of subjects: 120
Study 32798677 — intervention group
Group type: EXPERIMENTAL
Intervention: AFQ technique
Number of subjects: 120
Study 32798677 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine Learning classifier analysis
Number of subjects: 120
Study 616849227 — intervention group
Group type: EXPERIMENTAL
Intervention: Mouldway orthokeratology lenses (M‐OK)
Number of subjects: 240
Study 616849227 — intervention group
Group type: EXPERIMENTAL
Intervention: Medcall lenses (ML)
Number of subjects: 240
Study 616849227 — intervention group
Group type: COMPARATOR
Intervention: Ordinary frame glasses (OFG)
Number of subjects: 240
Study 33545575 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 0
Study 35831900 — intervention group
Group type: EXPERIMENTAL
Intervention: PC‐A/C with a 25% reduction in ventilator rate
Number of subjects: 36
Study 35831900 — intervention group
Group type: EXPERIMENTAL
Intervention: CSV (CPAP + PS)
Number of subjects: 36
Study 35831900 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing pressure support
Number of subjects: 36
Study 35831900 — intervention group
Group type: COMPARATOR
Intervention: CSV mode of ventilation
Number of subjects: 36
Study 35831900 — intervention group
Group type: COMPARATOR
Intervention: PC‐A/C mode
Number of subjects: 36
Study 33630732 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-operative treatment pathway (broad-spectrum antibiotics and active observation)
Number of subjects: 115
Study 33630732 — intervention group
Group type: COMPARATOR
Intervention: Appendicectomy
Number of subjects: 115
Study 33630732 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative work
Number of subjects: 115
Study 33630732 — intervention group
Group type: EXPERIMENTAL
Intervention: Health economic study
Number of subjects: 115
Study 33630732 — intervention group
Group type: EXPERIMENTAL
Intervention: Core outcome set development
Number of subjects: 115
Study 33630732 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey of surgeons
Number of subjects: 115
Study 33292009 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP therapy (initially implemented)
Number of subjects: 1
Study 33292009 — intervention group
Group type: COMPARATOR
Intervention: Single-night sleep studies
Number of subjects: 1
Study 35362819 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharesource® (cloud-based RPM software)
Number of subjects: 15
Study 32783238 — intervention group
Group type: EXPERIMENTAL
Intervention: High-proanthocyanidin cranberry juice (44 mg proanthocyanidin/240-mL serving) consumed twice daily for 8 weeks
Number of subjects: 522
Study 32783238 — intervention group
Group type: COMPARATOR
Intervention: Medium-proanthocyanidin cranberry juice
Number of subjects: 522
Study 32783238 — intervention group
Group type: COMPARATOR
Intervention: Low-proanthocyanidin cranberry juice
Number of subjects: 522
Study 32783238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 522
Study 32783238 — intervention group
Group type: COMPARATOR
Intervention: Encapsulated cranberry powder
Number of subjects: 522
Study 35065664 — intervention group
Group type: EXPERIMENTAL
Intervention: READ-IT programme
Number of subjects: 48
Study 35065664 — intervention group
Group type: COMPARATOR
Intervention: Usual practice
Number of subjects: 48
Study 34890567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive high-dose adalimumab plus thiopurine (160 mg adalimumab once per week for 4 weeks followed by 40 mg every 2 weeks, with escalation of dose at 4 months and 8 months if needed; initial dose of azathioprine 2·5 mg/kg or mercaptopurine 1·5 mg/kg)
Number of subjects: 77
Study 34890567 — intervention group
Group type: COMPARATOR
Intervention: Standard adalimumab monotherapy (160 mg at week 0, 80 mg at week 2, then 40 mg every 2 weeks)
Number of subjects: 77
Study 34890567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive high-dose adalimumab plus thiopurine
Number of subjects: 77
Study 34890567 — intervention group
Group type: COMPARATOR
Intervention: Standard adalimumab monotherapy
Number of subjects: 77
Study 32966148 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitors
Number of subjects: 0
Study 35851008 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural spinal cord stimulation (eSCS)
Number of subjects: 0
Study 33006007 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Displacement Plethysmography (ADP)
Number of subjects: 65
Study 33006007 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-Energy X-Ray Absorptiometry (DXA)
Number of subjects: 65
Study 33006007 — intervention group
Group type: EXPERIMENTAL
Intervention: Sum of Skinfolds (∑SFT)
Number of subjects: 65
Study 35179731 — intervention group
Group type: EXPERIMENTAL
Intervention: Early warning system (EWS) using a supervised machine learning algorithm for detection of EAHs.
Number of subjects: 50
Study 35508304 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced LiFE (mobile health device delivered)
Number of subjects: 0
Study 35508304 — intervention group
Group type: COMPARATOR
Intervention: Adapted LiFE (paper-based)
Number of subjects: 0
Study 32008420 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting cancer-specific survival (CSS)
Number of subjects: 0
Study 35638317 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (maximum 60 mg/daily for 18 weeks)
Number of subjects: 25
Study 33514390 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal plasma CMV-DNAemia of > 50 copies/mL
Number of subjects: 177
Study 33514390 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected mothers with CMV-DNAemia
Number of subjects: 177
Study 33514390 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected but non-transmitting mothers with CMV-DNAemia of > 50 copies/mL
Number of subjects: 177
Study 32831069 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole 30d/150 mg
Number of subjects: 0
Study 32831069 — intervention group
Group type: COMPARATOR
Intervention: Benznidazole 60d/300 mg
Number of subjects: 0
Study 36107420 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Simulation (VR Sim)
Number of subjects: 58
Study 36107420 — intervention group
Group type: COMPARATOR
Intervention: Plastic Manikin Simulation (PM Sim)
Number of subjects: 58
Study 32673939 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized PEEP ventilation
Number of subjects: 96
Study 32673939 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PEEP)
Number of subjects: 96
Study 33092399 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced fluence CXL (3.8 J/cm2, 7 min)
Number of subjects: 38
Study 33092399 — intervention group
Group type: COMPARATOR
Intervention: Standard CXL (5.4 J/cm2, 10 min)
Number of subjects: 38
Study 33071159 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring weight in SNFs
Number of subjects: 320
Study 33071159 — intervention group
Group type: EXPERIMENTAL
Intervention: Documentation of HF-related signs or symptoms
Number of subjects: 320
Study 33071159 — intervention group
Group type: COMPARATOR
Intervention: Health Inspection Star Rating
Number of subjects: 320
Study 35387819 — intervention group
Group type: EXPERIMENTAL
Intervention: Nelfinavir with chemoradiation and brachytherapy
Number of subjects: 348
Study 35387819 — intervention group
Group type: COMPARATOR
Intervention: Chemoradiation and brachytherapy alone
Number of subjects: 348
Study 34599253 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 respirator
Number of subjects: 44
Study 34599253 — intervention group
Group type: COMPARATOR
Intervention: No face covering
Number of subjects: 44
Study 32551736 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtually delivered Body Project (vBP)
Number of subjects: 149
Study 32551736 — intervention group
Group type: COMPARATOR
Intervention: Expressive writing (EW)
Number of subjects: 149
Study 32551736 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 149
Study 35300651 — intervention group
Group type: EXPERIMENTAL
Intervention: Open Rives sublay technique
Number of subjects: 93
Study 35300651 — intervention group
Group type: EXPERIMENTAL
Intervention: Segregation component technique
Number of subjects: 93
Study 35300651 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 93
Study 33623970 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 0
Study 32787905 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM formulae (Tiaogan‐BuXu‐Jiedu granules) plus ETV 0.5 mg per day for 96 weeks
Number of subjects: 490
Study 32787905 — intervention group
Group type: COMPARATOR
Intervention: TCM granule placebo plus ETV 0.5 mg per day for 96 weeks
Number of subjects: 490
Study 33397300 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia DVD education
Number of subjects: 120
Study 33397300 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging education
Number of subjects: 120
Study 33397300 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional pamphlets)
Number of subjects: 120
Study 32422244 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulated online training with hands-on training supported by peers
Number of subjects: 808
Study 32422244 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face education by trained educators
Number of subjects: 808
Study 34784719 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional broth (CF) enriched with 5.6 g FOS/100 g
Number of subjects: 18
Study 34784719 — intervention group
Group type: COMPARATOR
Intervention: Control broth (CC) with 0.4 g maltodextrin/100 g
Number of subjects: 18
Study 32825994 — intervention group
Group type: EXPERIMENTAL
Intervention: Saddle Hippotherapy Group
Number of subjects: 30
Study 32825994 — intervention group
Group type: EXPERIMENTAL
Intervention: Blanket Hippotherapy Group
Number of subjects: 30
Study 32825994 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 30
Study 37291264 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (20 min, 2 mA)
Number of subjects: 18
Study 37291264 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 18
Study 37291264 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 18
Study 33608485 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HI)
Number of subjects: 394
Study 33608485 — intervention group
Group type: COMPARATOR
Intervention: Low-to-Moderate Intensity Exercise (LMI)
Number of subjects: 394
Study 32817358 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacosamide (up to 12 mg/kg/day or 400 mg/day)
Number of subjects: 242
Study 32817358 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 242
Study 35633927 — intervention group
Group type: EXPERIMENTAL
Intervention: PRECEDE management intervention
Number of subjects: 112
Study 35633927 — intervention group
Group type: COMPARATOR
Intervention: Control group (125 doctors)
Number of subjects: 112
Study 32331820 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery (lobectomy, pneumonectomy, sublobar resection)
Number of subjects: 88
Study 32331820 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 88
Study 32331820 — intervention group
Group type: EXPERIMENTAL
Intervention: Both modalities (surgery and radiotherapy)
Number of subjects: 88
Study 32348303 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative data collection through in-depth interviews, participant observation, and photovoice over 18 months.
Number of subjects: 15
Study 32348303 — intervention group
Group type: EXPERIMENTAL
Intervention: Social norms and reproductive agency (distributed agency) influencing decision-making.
Number of subjects: 15
Study 36170448 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurture Intervention (FNI)
Number of subjects: 0
Study 36170448 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 34161883 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine therapy (ET) with letrozole+ribociclib
Number of subjects: 194
Study 34161883 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 194
Study 33569865 — intervention group
Group type: EXPERIMENTAL
Intervention: MLV‐RAL 0.05%/0.1% cream
Number of subjects: 23
Study 33569865 — intervention group
Group type: COMPARATOR
Intervention: Retinol 0.05%/0.1% cream
Number of subjects: 23
Study 34980827 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of an oxygen-enriched oil-based gel, applied 3 times daily for 10 days
Number of subjects: 30
Study 34187387 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus active cycling in bed
Number of subjects: 51
Study 34187387 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 51
Study 32101996 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction therapy (IT)
Number of subjects: 4388
Study 32101996 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithymocyte globulin (IT)
Number of subjects: 4388